Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer

por Zheng, Jia Bo, Wong, Chau Wei, Liu, Jia, Luo, Xiao-Jing, Zhou, Wei-Yi, Chen, Yan-Xing, Luo, Hui-Yan, Zeng, Zhao-Lei, Ren, Chao, Xie, Xiao-Ming, Wang, De-Shen
Publicado 2022

LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription

por Luo, Xiao-Jing, He, Ming-Ming, Liu, Jia, Zheng, Jia-Bo, Wu, Qi-Nian, Chen, Yan-Xing, Meng, Qi, Luo, Kong-Jia, Chen, Dong-Liang, Xu, Rui-Hua, Zeng, Zhao-Lei, Liu, Ze-Xian, Luo, Hui-Yan
Publicado 2022

The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer

por Zeng, Zhao‐lei, Lu, Jia‐huan, Wang, Yun, Sheng, Hui, Wang, Ying‐nan, Chen, Zhan‐hong, Wu, Qi‐nian, Zheng, Jia‐Bo, Chen, Yan‐xing, Yang, Dong‐dong, Yu, Kai, Mo, Hai‐yu, Hu, Jia‐jia, Hu, Pei‐shan, Liu, Ze‐xian, Ju, Huai‐qiang, Xu, Rui‐Hua
Publicado 2021